NCT04305834View on ClinicalTrials.gov

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

PHASE2RecruitingINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 25, 2020

Primary Completion Date

August 21, 2026

Study Completion Date

August 21, 2026

Conditions
Anatomic Stage IV Breast Cancer AJCC v8Hormone Receptor Positive Breast CarcinomaMetastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8
Interventions
DRUG

Abemaciclib

Given PO

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (3)

14203

RECRUITING

Roswell Park Comprehensive Cancer Center, Buffalo

91010

RECRUITING

City of Hope Medical Center, Duarte

02215

RECRUITING

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER